Pinnacle Biologics owns the marketing and distribution rights to MedImmune’s Ethyol, 50mg/ml, powder for solution for infusion in Western Europe, Turkey and Israel. Guillermo Herrera, chairman of the
Lijia will use a combination of two Shining probiotics, Bifidobacterium adolescentis and Bifidobacterium infantis, as additives in its newly developed dietary supplement powders and tablets. These probiotics will
This 36-month, open-label Phase II study, running concurrently with the pivotal Phase III Fame study is designed primarily to assess systemic exposure of the corticosteroid, fluocinolone acetonide (FA),
After 48 weeks of therapy, all patients responding to treatment have now completed their 24-week follow-up. The unblinded data from the trial are expected to be available in
This Phase III, multi-center, placebo-controlled, four-week trial evaluated 322 patients with chronic primary insomnia. Patients were randomized to receive either 20mg or 50mg of tasimelteon or placebo over
Mr Richard replaces Jim Bixby, who will continue as a member of the board of directors. Mr Richard most recently served as senior vice president of sales and
The acquisition will expand IPC’s presence to Southeast Florida with a network of independent physicians who perform hospitalist services on a part-time basis for Hospitalists of America’s (HOA)
The analysis found that preemptive treatment reduced the incidence rate of grade 2 and greater skin toxicities by over 50% without additional side effects when compared to reactive
The structure of this transaction is expected to be accretive, exclusive of financing costs, in the first full year of operations. Inlog’s management is planning to stay with
Between March and June 2008, 556 patients were screened for the randomized, double-blind, placebo-controlled trial, of which 430 were enrolled. The participants will be observed at 31 clinical
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.